Regulatory Requirements for Medical Silicones
Silicone materials used in medical device lubrication and construction must meet multiple overlapping regulatory standards depending on the contact type and duration. USP <661> / USP Class VI testing encompasses cytotoxicity, systemic injection, and intracutaneous reactivity tests — all three must pass for body-contact applications. ISO 10993-5 addresses cytotoxicity; ISO 10993-10 covers sensitization; ISO 10993-4 governs hemolysis testing for blood-contact devices specifically.
On the fluid side, FDA 21 CFR 177.2600 covers silicone elastomers and 21 CFR 178.3570 covers silicone fluids as lubricants in food and drug manufacturing contact. CE marking under EU MDR 2017/745 requires biocompatibility testing per ISO 10993-1 for all implants and Class II/III devices, making ISO 10993 compliance effectively mandatory for European market access.
Applications and Silicone Grades
| Application | Silicone Form | Key Spec |
|---|---|---|
| Catheter lubricant | PDMS fluid 350 cSt | USP Class VI, sterile filterable |
| Syringe barrel coating | PDMS 1000 cSt | FDA, low particulates |
| Implant surface coating | Thin PDMS film | ISO 10993, low extractables |
| Peristaltic pump tubing | Platinum LSR | USP Class VI, compression set <10% |
| Wound drainage tubing | Medical HTV | ISO 10993-5 pass |
Lubrication of Catheters and Syringes
Catheter lubrication is applied at 0.5–3 mg PDMS/cm² by dip coating or spray, followed by drying at 80–100 °C to remove solvent and bond the coating. This reduces catheter insertion force by 40–70%, directly improving patient comfort and clinical ease of placement.
Syringe barrel siliconization applies 0.1–0.5 mg PDMS/cm², reducing both break-loose force (the initial force to move the plunger from rest) and ongoing glide force. For pre-filled syringes (PFS), the lubrication coating must remain stable over a 2-year shelf life without migrating into the drug product or generating excessive extractables. High-viscosity PDMS at 1000 cSt is preferred over low-viscosity grades for PFS applications because it migrates less and produces lower particulate counts in the injectable drug product.
Extractables and Leachables
Drug-device combination products — pre-filled syringes, drug-eluting catheters — face the most stringent extractable and leachable (E&L) requirements. Low-extractable PDMS grades must contain <5 ppm cyclic siloxanes (D4/D5/D6 combined) by GC-MS analysis. Platinum catalyst residuals in platinum-cured LSR parts must be held to <0.5 ppm, verified by ICP-MS on finished parts or representative samples. European Pharmacopoeia 3.1.9 establishes specific extractable limits for silicone elastomers used in closures and tubing in contact with pharmaceutical products.
Related Reading
USP Class VI Silicone Rubber · FDA 21 CFR Silicone Rubber · Food-Grade Silicone Oil